NTAP:NASDAQNetApp, Inc. Analysis
Data as of 2026-03-11 - not real-time
$96.91
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
NetApp delivered a Q3 earnings beat, with revenue expanding modestly and margins remaining robust, supporting a dividend yield above 2% and a payout ratio under 40%. Strong cash generation and a net cash position (cash exceeds debt) reinforce the sustainability of the dividend and provide flexibility for growth initiatives in hybrid and public cloud services.
On the technical side, the stock trades just above its 30‑day support level, with an RSI in the low‑mid 40s and a bearish MACD crossover, suggesting short‑term downside pressure. However, the price sits well below the DCF‑derived fair value and the consensus target median, offering roughly a 20% upside. Relative to its peers, NetApp’s PE is markedly lower than the industry average, indicating an undervalued positioning despite a high beta and elevated short‑term volatility.
On the technical side, the stock trades just above its 30‑day support level, with an RSI in the low‑mid 40s and a bearish MACD crossover, suggesting short‑term downside pressure. However, the price sits well below the DCF‑derived fair value and the consensus target median, offering roughly a 20% upside. Relative to its peers, NetApp’s PE is markedly lower than the industry average, indicating an undervalued positioning despite a high beta and elevated short‑term volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near technical support
- Bearish MACD and neutral RSI
- Recent earnings beat provides short‑term cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation gap of ~20% to fair value
- Strong cash flow and dividend sustainability
- Growth momentum in hybrid‑cloud offerings
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Stable dividend yield with low payout ratio
- Strategic positioning in enterprise data‑infrastructure market
- Long‑term upside potential reflected in analyst target median
Key Metrics & Analysis
Financial Health
Revenue Growth4.40%
Profit Margin18.07%
P/E Ratio16.3
ROE112.59%
ROA10.27%
Debt/Equity236.10
P/B Ratio16.6
Op. Cash Flow$1.8B
Free Cash Flow$1.1B
Industry P/E36.8
Technical Analysis
TrendBearish
RSI41.2
Support$95.91
Resistance$107.05
MA 20$100.91
MA 50$102.04
MA 200$109.01
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value$96.08
Target Price$117.93
Upside/Downside21.69%
GradeUndervalued
TypeBlend
Dividend Yield2.15%
Risk Assessment
Beta1.36
Volatility38.95%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.